Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Repare Therapeutics Inc.

    NASDAQ: RPTX · Real-Time Price · USD
    1.45
    0.00 (0.00%)
    At close: Jun 17, 2025, 12:07 PM

    Repare Therapeutics Statistics

    Share Statistics

    Repare Therapeutics has 42.89M shares outstanding. The number of shares has increased by 0.15% in one year.

    Shares Outstanding

    n/a
    		 42.89M

    Shares Change (YoY)

    n/a
    		 0.15%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 72.15%

    Shares Floating

    n/a
    		 30.77M

    Failed to Deliver (FTD) Shares

    n/a
    		 6,155

    FTD / Avg. Volume

    n/a
    		 2.15%

    Short Selling Information

    The latest short interest is 562.11K, so 1.31% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 562.11K

    Short % of Shares Out

    n/a
    		 1.31%

    Short % of Float

    n/a
    		 1.93%

    Short Ratio (days to cover)

    n/a
    		 4.53

    Valuation Ratios

    The PE ratio is -0.66 and the forward PE ratio is -0.95. Repare Therapeutics's PEG ratio is 0.06.

    PE Ratio

    n/a
    		 -0.66

    Forward PE

    n/a
    		 -0.95

    PS Ratio

    n/a
    		 1.04

    Forward PS

    n/a
    		 0.4

    PB Ratio

    n/a
    		 0.37

    P/FCF Ratio

    n/a
    		 -0.73

    PEG Ratio

    n/a
    		 0.06
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Repare Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 6.77, with a Debt / Equity ratio of 0.01.

    Current Ratio

    n/a
    		 6.77

    Quick Ratio

    n/a
    		 6.77

    Debt / Equity

    n/a
    		 0.01

    Debt / EBITDA

    n/a
    		 -0.02

    Debt / FCF

    n/a
    		 -0.03

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $414,550.39

    Profits Per Employee

    n/a
    		 $-656,503.88

    Employee Count

    n/a
    		 129

    Asset Turnover

    n/a
    		 0.3

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 1.44M

    Effective Tax Rate

    n/a
    		 -1.73%

    Stock Price Statistics

    The stock price has increased by -61.58% in the last 52 weeks. The beta is 0.83, so Repare Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.83

    52-Week Price Change

    n/a
    		 -61.58%

    50-Day Moving Average

    n/a
    		 1.3

    200-Day Moving Average

    n/a
    		 2.02

    Relative Strength Index (RSI)

    n/a
    		 57.98

    Average Volume (20 Days)

    n/a
    		 286,893

    Income Statement

    In the last 12 months, Repare Therapeutics had revenue of 53.48M and earned -84.69M in profits. Earnings per share was -2.

    Revenue

    n/a
    		 53.48M

    Gross Profit

    n/a
    		 51.56M

    Operating Income

    n/a
    		 -93.52M

    Net Income

    n/a
    		 -84.69M

    EBITDA

    n/a
    		 -93.52M

    EBIT

    n/a
    		 -92.14M

    Earnings Per Share (EPS)

    n/a
    		 -2
    Full Income Statement

    Balance Sheet

    The company has 84.72M in cash and 1.93M in debt, giving a net cash position of 82.78M.

    Cash & Cash Equivalents

    n/a
    		 84.72M

    Total Debt

    n/a
    		 1.93M

    Net Cash

    n/a
    		 82.78M

    Retained Earnings

    n/a
    		 -417.8M

    Total Assets

    n/a
    		 144.02M

    Working Capital

    n/a
    		 121.42M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -76.44M and capital expenditures 0, giving a free cash flow of -76.44M.

    Operating Cash Flow

    n/a
    		 -76.44M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -76.44M

    FCF Per Share

    n/a
    		 -1.8
    Full Cash Flow Statement

    Margins

    Gross margin is 96.41%, with operating and profit margins of -174.88% and -158.37%.

    Gross Margin

    n/a
    		 96.41%

    Operating Margin

    n/a
    		 -174.88%

    Pretax Margin

    n/a
    		 -155.67%

    Profit Margin

    n/a
    		 -158.37%

    EBITDA Margin

    n/a
    		 -174.88%

    EBIT Margin

    n/a
    		 -174.88%

    FCF Margin

    n/a
    		 -142.95%

    Dividends & Yields

    RPTX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for RPTX is $4.5, which is 208.2% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $4.5

    Price Target Difference

    n/a
    		 208.2%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 3
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -4.85

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist